Axsome Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	6,880	3,275	2,957	2,780	1,052	2,228
Market Cap Growth	72.32%	10.77%	6.36%	164.34%	-52.81%	-22.43%
Enterprise Value	6,802	3,167	2,775	2,669	1,004	2,115
Last Close Price	135.46	67.31	62.30	62.32	28.58	62.25
PS Ratio	16.48	10.63	13.92	66.94	-	-
PB Ratio	125.44	71.92	19.72	30.57	91.10	26.74
P/TBV Ratio	472.84	-	29.97	84.61	91.10	26.74
EV/Sales Ratio	16.54	10.28	13.06	64.28	-	-
Debt / Equity Ratio	2.97	3.38	0.98	0.86	3.18	0.44
Net Debt / Equity Ratio	-1.45	-2.15	-1.05	-0.97	-2.35	-1.17
Net Debt / EBITDA Ratio	0.57	0.50	1.14	0.62	0.30	1.35
Net Debt / FCF Ratio	1.05	0.95	1.37	0.91	0.34	1.70
Asset Turnover	0.91	0.67	0.59	0.24	-	-
Inventory Turnover	2.40	2.16	2.68	-	-	-
Quick Ratio	1.45	1.99	3.46	2.47	3.75	7.85
Current Ratio	1.57	2.11	3.63	2.54	3.75	7.85
Return on Equity (ROE)	-275.50%	-231.63%	-159.21%	-298.97%	-201.51%	-70.36%
Return on Assets (ROA)	-19.79%	-27.28%	-24.86%	-52.30%	-56.91%	-30.46%
Return on Capital Employed (ROCE)	-63.10%	-74.60%	-40.70%	-74.70%	-192.70%	-60.90%
Earnings Yield	-2.48%	-7.00%	-6.35%	-5.59%	-9.16%	-3.38%
FCF Yield	-1.10%	-3.14%	-3.87%	-3.50%	-7.62%	-2.58%
Buyback Yield / Dilution	-3.38%	-5.48%	-11.73%	-8.07%	-1.11%	-9.37%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.